{"id":4510,"date":"2023-04-27T16:39:38","date_gmt":"2023-04-27T14:39:38","guid":{"rendered":"https:\/\/www.asimas.it\/new_asimas\/?p=4510"},"modified":"2023-04-27T16:41:25","modified_gmt":"2023-04-27T14:41:25","slug":"mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing","status":"publish","type":"post","link":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/","title":{"rendered":"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing"},"content":{"rendered":"\n<p>Dalla voce di<strong>\u00a0Enrico Heffler<\/strong>, Direttore Scuola di Specializzazione in Allergologia e Immunologia dell\u2019Humanitas University di Milano, i dati practice-changing dello studio<strong> PIONEER,\u00a0<\/strong>presentati all\u2019ultima edizione dell\u2019AAAAI Meeting, che evidenziano efficacia e sicurezza di avapritinib nel trattamento della<strong>\u00a0mastocitosi sistemica indolente<\/strong>.<\/p>\n<p>Buona visione!<\/p><br><br><br>\n<p><iframe loading=\"lazy\" title=\"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/G1mWV8RzhXk?start=5&amp;feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dalla voce di\u00a0Enrico Heffler, Direttore Scuola di Specializzazione in Allergologia e Immunologia dell\u2019Humanitas University di Milano, i dati practice-changing dello studio PIONEER,\u00a0presentati all\u2019ultima edizione dell\u2019AAAAI Meeting, che evidenziano efficacia e sicurezza di avapritinib nel trattamento della\u00a0mastocitosi sistemica indolente. Buona visione!<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,2],"tags":[],"class_list":["post-4510","post","type-post","status-publish","format-standard","hentry","category-20","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing - Asimas<\/title>\r\n<meta name=\"robots\" content=\"noindex, follow\" \/>\r\n<meta property=\"og:locale\" content=\"it_IT\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing - Asimas\" \/>\r\n<meta property=\"og:description\" content=\"Dalla voce di\u00a0Enrico Heffler, Direttore Scuola di Specializzazione in Allergologia e Immunologia dell\u2019Humanitas University di Milano, i dati practice-changing dello studio PIONEER,\u00a0presentati all\u2019ultima edizione dell\u2019AAAAI Meeting, che evidenziano efficacia e sicurezza di avapritinib nel trattamento della\u00a0mastocitosi sistemica indolente. Buona visione!\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/\" \/>\r\n<meta property=\"og:site_name\" content=\"Asimas\" \/>\r\n<meta property=\"article:published_time\" content=\"2023-04-27T14:39:38+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2023-04-27T14:41:25+00:00\" \/>\r\n<meta name=\"author\" content=\"Dani\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dani\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/\"},\"author\":{\"name\":\"Dani\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#\\\/schema\\\/person\\\/f4cff0d0946e80b069d013531ab38b84\"},\"headline\":\"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing\",\"datePublished\":\"2023-04-27T14:39:38+00:00\",\"dateModified\":\"2023-04-27T14:41:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/\"},\"wordCount\":68,\"publisher\":{\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#organization\"},\"articleSection\":[\"2023\",\"News\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/\",\"url\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/\",\"name\":\"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing - Asimas\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#website\"},\"datePublished\":\"2023-04-27T14:39:38+00:00\",\"dateModified\":\"2023-04-27T14:41:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#website\",\"url\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/\",\"name\":\"Asimas\",\"description\":\"Associazione Italiana Mastocitosi\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#organization\",\"name\":\"ASIMAS - Associazione Italiana Mastocitosi\",\"url\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/logo-asimas.png\",\"contentUrl\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/logo-asimas.png\",\"width\":240,\"height\":240,\"caption\":\"ASIMAS - Associazione Italiana Mastocitosi\"},\"image\":{\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/#\\\/schema\\\/person\\\/f4cff0d0946e80b069d013531ab38b84\",\"name\":\"Dani\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5fe72d43bdc0300c112cdc12797aa2f193d514f9d4f81fde0e8ae4b3921fb63e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5fe72d43bdc0300c112cdc12797aa2f193d514f9d4f81fde0e8ae4b3921fb63e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5fe72d43bdc0300c112cdc12797aa2f193d514f9d4f81fde0e8ae4b3921fb63e?s=96&d=mm&r=g\",\"caption\":\"Dani\"},\"url\":\"https:\\\/\\\/www.asimas.it\\\/new_asimas\\\/author\\\/admin\\\/\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing - Asimas","robots":{"index":"noindex","follow":"follow"},"og_locale":"it_IT","og_type":"article","og_title":"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing - Asimas","og_description":"Dalla voce di\u00a0Enrico Heffler, Direttore Scuola di Specializzazione in Allergologia e Immunologia dell\u2019Humanitas University di Milano, i dati practice-changing dello studio PIONEER,\u00a0presentati all\u2019ultima edizione dell\u2019AAAAI Meeting, che evidenziano efficacia e sicurezza di avapritinib nel trattamento della\u00a0mastocitosi sistemica indolente. Buona visione!","og_url":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/","og_site_name":"Asimas","article_published_time":"2023-04-27T14:39:38+00:00","article_modified_time":"2023-04-27T14:41:25+00:00","author":"Dani","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Dani","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/#article","isPartOf":{"@id":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/"},"author":{"name":"Dani","@id":"https:\/\/www.asimas.it\/new_asimas\/#\/schema\/person\/f4cff0d0946e80b069d013531ab38b84"},"headline":"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing","datePublished":"2023-04-27T14:39:38+00:00","dateModified":"2023-04-27T14:41:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/"},"wordCount":68,"publisher":{"@id":"https:\/\/www.asimas.it\/new_asimas\/#organization"},"articleSection":["2023","News"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/","url":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/","name":"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing - Asimas","isPartOf":{"@id":"https:\/\/www.asimas.it\/new_asimas\/#website"},"datePublished":"2023-04-27T14:39:38+00:00","dateModified":"2023-04-27T14:41:25+00:00","breadcrumb":{"@id":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.asimas.it\/new_asimas\/mastocitosi-sistemica-indolente-dallo-studio-pioneer-dati-practice-changing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.asimas.it\/new_asimas\/"},{"@type":"ListItem","position":2,"name":"Mastocitosi sistemica indolente, dallo studio PIONEER dati practice-changing"}]},{"@type":"WebSite","@id":"https:\/\/www.asimas.it\/new_asimas\/#website","url":"https:\/\/www.asimas.it\/new_asimas\/","name":"Asimas","description":"Associazione Italiana Mastocitosi","publisher":{"@id":"https:\/\/www.asimas.it\/new_asimas\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.asimas.it\/new_asimas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.asimas.it\/new_asimas\/#organization","name":"ASIMAS - Associazione Italiana Mastocitosi","url":"https:\/\/www.asimas.it\/new_asimas\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.asimas.it\/new_asimas\/#\/schema\/logo\/image\/","url":"https:\/\/www.asimas.it\/new_asimas\/wp-content\/uploads\/2019\/04\/logo-asimas.png","contentUrl":"https:\/\/www.asimas.it\/new_asimas\/wp-content\/uploads\/2019\/04\/logo-asimas.png","width":240,"height":240,"caption":"ASIMAS - Associazione Italiana Mastocitosi"},"image":{"@id":"https:\/\/www.asimas.it\/new_asimas\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.asimas.it\/new_asimas\/#\/schema\/person\/f4cff0d0946e80b069d013531ab38b84","name":"Dani","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/5fe72d43bdc0300c112cdc12797aa2f193d514f9d4f81fde0e8ae4b3921fb63e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5fe72d43bdc0300c112cdc12797aa2f193d514f9d4f81fde0e8ae4b3921fb63e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5fe72d43bdc0300c112cdc12797aa2f193d514f9d4f81fde0e8ae4b3921fb63e?s=96&d=mm&r=g","caption":"Dani"},"url":"https:\/\/www.asimas.it\/new_asimas\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/posts\/4510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/comments?post=4510"}],"version-history":[{"count":4,"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/posts\/4510\/revisions"}],"predecessor-version":[{"id":4514,"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/posts\/4510\/revisions\/4514"}],"wp:attachment":[{"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/media?parent=4510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/categories?post=4510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.asimas.it\/new_asimas\/wp-json\/wp\/v2\/tags?post=4510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}